NARI
Price:
$45.52
Market Cap:
$2.65B
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove w...[Read more]
Industry
Medical - Devices
IPO Date
2020-05-22
Stock Exchange
NASDAQ
Ticker
NARI
According to Inari Medical, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -45.98. This represents a change of -510.83% compared to the average of 11.19 of the last 4 quarters.
The mean historical PE Ratio of Inari Medical, Inc. over the last ten years is -494.14. The current -45.98 PE Ratio has changed 830.50% with respect to the historical average. Over the past ten years (40 quarters), NARI's PE Ratio was at its highest in in the December 2019 quarter at 1.15K. The PE Ratio was at its lowest in in the March 2019 quarter at -429.97.
Average
-494.14
Median
-151.48
Minimum
-2252.78
Maximum
462.06
Discovering the peaks and valleys of Inari Medical, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.86%
Maximum Annual PE Ratio = 462.06
Minimum Annual Increase = -124.83%
Minimum Annual PE Ratio = -2252.78
Year | PE Ratio | Change |
---|---|---|
2023 | -2252.78 | 1.86% |
2022 | -114.75 | -124.83% |
2021 | 462.06 | 127.86% |
2020 | 202.79 | -118.88% |
2019 | -1073.96 | 470.60% |
The current PE Ratio of Inari Medical, Inc. (NARI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-635.16
5-year avg
-555.33
10-year avg
-494.14
Inari Medical, Inc.’s PE Ratio is less than ShockWave Medical, Inc. (76.34), less than Outset Medical, Inc. (-0.16), less than Legend Biotech Corporation (-30.94), less than Progyny, Inc. (34.69), greater than Axonics, Inc. (-2060.91),
Company | PE Ratio | Market cap |
---|---|---|
76.34 | $12.57B | |
-0.16 | $25.48M | |
-30.94 | $9.90B | |
34.69 | $2.09B | |
-2060.91 | $3.52B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Inari Medical, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Inari Medical, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Inari Medical, Inc.'s PE Ratio?
How is the PE Ratio calculated for Inari Medical, Inc. (NARI)?
What is the highest PE Ratio for Inari Medical, Inc. (NARI)?
What is the 3-year average PE Ratio for Inari Medical, Inc. (NARI)?
What is the 5-year average PE Ratio for Inari Medical, Inc. (NARI)?
How does the current PE Ratio for Inari Medical, Inc. (NARI) compare to its historical average?